We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
COPD Inhalers: The Sprinter and The Marathon Runner
Key Information
- How Inhalers Work: Inhalers are the main treatment for COPD. They relax the muscles around your airways, helping them open up so air can move more freely.
- Why This Matters: Understanding how and when to use your inhalers is key to controlling your symptoms and improving your day-to-day breathing.
The Two Types of Inhalers
To understand when to use each inhaler, think of them as a “Sprinter” and a “Marathon Runner.”
- 1. The Sprinter (Short-Acting Reliever)
Colour: Often blue.
When to use: When you suddenly feel breathless.
How it works: Acts quickly (within minutes) to give rapid relief.
Duration: Lasts for a few hours. - 2. The Marathon Runner (Long-Acting Maintenance)
When to use: Taken every day as prescribed (usually once or twice daily).
How it works: Works slowly and steadily in the background.
Duration: Keeps airways open for 12–24 hours.
Role: Prevents breathlessness and keeps symptoms under control long-term.
Importance of Technique
Using your inhaler correctly is essential. Even the best medicine will not work properly if it does not reach deep into your lungs.
If you are unsure about your technique, use the guide below.
If you would like to review your inhalers or have any concerns, please contact us.
Further Information
For more information about COPD, including symptoms, treatment and living with COPD, please visit the NHS website.
Last reviewed: 31 March 2026
Next review due: 31 March 2029